Showing 1 - 7 results of 7 for search 'Thiemo J.A. van Nijnatten', query time: 0.04s Refine Results
  1. 1
    Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype

    Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype by Cornelis M. de Mooij, Cristina Mitea, Felix M. Mottaghy, Marjolein L. Smidt, Thiemo J. A. van Nijnatten

    Published 2021-11-01
    Get full text
    Article
  2. 2
    Prevalence of Silicone Lymphadenopathy in Women with Breast Implants: A single-center retrospective study

    Prevalence of Silicone Lymphadenopathy in Women with Breast Implants: A single-center retrospective study by Juliënne A. Berben, Esther M. Heuts, Thiemo J.A. van Nijnatten, René R.W.J. van der Hulst

    Published 2025-06-01
    Get full text
    Article
  3. 3
    Critical dialogue: recent advancements toward omission of axillary lymph node dissection in clinically node positive breast cancer patients treated with neoadjuvant chemo-immuno therapy: impact on radiology practice

    Critical dialogue: recent advancements toward omission of axillary lymph node dissection in clinically node positive breast cancer patients treated with neoadjuvant chemo-immuno th... by Florien J. G. van Amstel, Janine M. Simons, Vivianne C. G. Tjan-Heijnen, Marjolein L. Smidt, Thiemo J. A. van Nijnatten

    Published 2025-03-01
    Get full text
    Article
  4. 4
    The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic review and meta-analysis

    The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic review and meta-analysis by Cornelis M. de Mooij, Roxanne A. W. Ploumen, Patty J. Nelemans, Felix M. Mottaghy, Marjolein L. Smidt, Thiemo J. A. van Nijnatten

    Published 2023-01-01
    Get full text
    Article
  5. 5
    Surgical treatment after neoadjuvant systemic therapy for HER2-positive invasive breast cancer in the Netherlands: 10-Year trends and the influence an accompanying DCIS component

    Surgical treatment after neoadjuvant systemic therapy for HER2-positive invasive breast cancer in the Netherlands: 10-Year trends and the influence an accompanying DCIS component by Roxanne A.W. Ploumen, Thiemo J.A. van Nijnatten, Loes F.S. Kooreman, Adri C. Voogd, Kristien B.M.I. Keymeulen, Sabine Siesling, Marjolein L. Smidt

    Published 2025-02-01
    Get full text
    Article
  6. 6
    [18F]FDG whole-body PET-MR including an integrated breast MR protocol for locoregional and distant staging in breast cancer patients—a feasibility study

    [18F]FDG whole-body PET-MR including an integrated breast MR protocol for locoregional and distant staging in breast cancer patients—a feasibility study by Thiemo J. A. van Nijnatten, Cornelis M. de Mooij, Cristina Mitea, Janneke Houwers, Maaike de Boer, Marjolein L. Smidt, Felix M. Mottaghy, Joachim E. Wildberger

    Published 2024-10-01
    Get full text
    Article
  7. 7
    The effect of neoadjuvant chemotherapy on ductal carcinoma in situ in triple-negative breast cancer patients: A nationwide analysis

    The effect of neoadjuvant chemotherapy on ductal carcinoma in situ in triple-negative breast cancer patients: A nationwide analysis by Eva L. Claassens, Roxanne A.W. Ploumen, Loes F.S. Kooreman, Maartje A.C.E. van Kats, Sabine Siesling, Thiemo J.A. van Nijnatten, Marjolein L. Smidt

    Published 2025-04-01
    Get full text
    Article

Search Tools: